StockData
United Health Products, Inc. logo

United Health Products, Inc. (UEEC) stock

UEECOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 0/30
$0.04−0.01 (-23.53%)

Close on Oct 19, 2026Market cap $10.25MP/E –Yield –

United Health Products, Inc. reported revenue of $0 for the twelve months to Sep 30, 2026. At the latest close the market valued the company at $10.25M.

Revenue
$0
TTM Q3 2026
Operating income
-$829.64K
TTM Q3 2026
EPS, diluted
$0.00
TTM Q3 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$10.25M
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$0
Net income
-$1.30M
EPS, diluted
$0.00
Book value per share
-$0.02
Diluted shares
263M

Trading

Previous close
$0.05
Open
$0.05
Day's range
$0.04 – $0.05
Volume
277,990
Average volume (20 days)
60,244

Market cap history

Month-end market cap since 2011, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodUEECS&P 500DifferenceUEEC per yearS&P 500 per year
1 month+16.8%+0.6%+16.1 pts
3 months-24.3%+3.4%−27.6 pts
Year to date-28.6%+13.3%−41.8 pts
1 year-33.3%+16.6%−49.9 pts
3 years-86.1%+86.4%−172.4 pts-48.2%+23.1%
5 years-95.8%+81.9%−177.7 pts-47.0%+12.7%
10 years-54.1%+318.9%−373.0 pts-7.5%+15.4%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$0

Gross profit

–

Operating income

-$829.64K

Net income

-$1.30M

EPS, diluted

$0.00

Free cash flow

–
Reported periodTrailing twelve months

Press releases

Releases United Health Products filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About United Health Products

Orthopedic, Prosthetic & Surgical Appliances & Supplies

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze for healthcare and wound care applications. Its primary product is CelluSTAT, a cotton-derived gauze that absorbs wound exudate and helps control bleeding. The company targets human surgical and wound care segments, including external trauma and internal surgical procedures. Its potential customer base includes hospitals, surgery centers, outpatient clinics, emergency medical services, and military medical providers. It also identifies hemodialysis centers, nursing homes, dental offices, and veterinary clinics as prospective clients.

Company profile, executives and history

United Health Products stock: common questions

What is United Health Products's stock price?

UEEC closed at $0.04 on Oct 19, 2026, down 23.53% on the day.

What is United Health Products's market cap?

United Health Products was worth $10.25M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is UEEC's P/E ratio?

United Health Products lost money over the twelve months to Sep 30, 2026 (diluted EPS $0.00), so it has no meaningful P/E ratio.

How much revenue does United Health Products make?

United Health Products reported revenue of $0 for the twelve months to Sep 30, 2026.

Does United Health Products pay a dividend?

No. United Health Products has not paid a cash dividend over the last twelve months.

How has UEEC stock performed over the past year?

Including dividends, UEEC returned -33.3% over the past year, against +16.6% for the S&P 500.

Who are United Health Products's competitors?

Companies most similar to United Health Products by business, industry and size include SMTI, CUPR, FEED, MDXG, ZJYL.

See a number that looks wrong?